INTERNATIONAL STEM CELL CORPORATION

ISCO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $7.5M $7.2M $7.6M $7.0M $6.1M $4.6M $4.5M $1.6M
Cost of Revenue $2.1M $1.9M $2.1M $1.9M $1.6M $1.3M $1.6M $725.0K
Gross Profit $5.3M $5.2M $5.5M $5.1M $4.5M $3.3M $2.9M $843.0K
Gross Margin 71.5% 72.9% 72.8% 72.6% 73.3% 72.1% 64.3% 53.8%
Operating Expenses
Research & Development $2.7M $2.9M $2.7M $5.4M $3.6M $3.6M $4.4M $3.4M
SG&A Expense $5.2M $4.7M $4.7M $5.6M $6.0M $7.4M $8.4M $7.1M
Operating Income $-4.9M $-4.9M $-4.6M $-8.7M $-7.5M $-9.8M $-11.4M $-10.5M
Operating Margin -66.3% -67.7% -60.4% -123.7% -122.8% -214.9% -250.6% -667.2%
Interest Expense $59.0K $6.0K $11.0K $2.0K $3.0K $2.0K $14.0K
Pretax Income $-6.1M $-1.1M $-2.6M $-12.5M $-10.5M $-9.8M $-9.2M $-12.7M
Income Tax Expense $0 $0 $0 $0 $0
Net Income $-6.1M $-1.1M $-2.6M $-12.5M $-10.5M $-9.8M $-9.2M $-12.7M
Net Margin -81.4% -15.1% -34.9% -177.8% -170.5% -215.3% -202.4% -811.4%
EPS (Basic) $-1.46 $-0.34 $-1.33 $-9.71 $-0.09 $-0.13 $-0.12 $-0.21
EPS (Diluted) $-1.46 $-0.34 $-2.26 $-10.34 $-0.09 $-0.13 $-0.12 $-0.21
Shares Outstanding (Basic) 4.2M 3.2M 2.0M 1.3M 151.2M 87.4M 80.0M 74.8M
Shares Outstanding (Diluted) 4.2M 3.2M 2.0M 1.2M 151.2M 87.4M 80.0M 74.8M
Dividends Per Share
← Newer Page 2 of 2 Older →